Qassim Health Cluster

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Mepivacaine 2% with epinephrine 1:100,000 · Anesthesiology
Mepivacaine is a local anesthetic that blocks sodium channels to prevent nerve impulses, while epinephrine constricts blood vessels to prolong the anesthetic effect.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Qassim Health Cluster portfolio CI brief
Qassim Health Cluster pipeline updates RSS

Frequently asked questions about Qassim Health Cluster

What is Qassim Health Cluster's pipeline?

Qassim Health Cluster has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Mepivacaine 2% with epinephrine 1:100,000.

Sector hub: All tracked pharma companies